Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000147552 | SCV000194999 | uncertain significance | Congenital muscular hypertrophy-cerebral syndrome | 2014-05-08 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000356126 | SCV000335031 | benign | not specified | 2015-09-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000147552 | SCV000760993 | benign | Congenital muscular hypertrophy-cerebral syndrome | 2024-01-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316948 | SCV000850959 | benign | Inborn genetic diseases | 2017-06-14 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001529713 | SCV001824983 | likely benign | not provided | 2021-04-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001529713 | SCV004010938 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | SMC1A: BP4, BS2 |
Diagnostic Laboratory, |
RCV001529713 | SCV001743639 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001529713 | SCV001931580 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529713 | SCV001967631 | likely benign | not provided | no assertion criteria provided | clinical testing |